HCW Biologics Files 8-K: Routine Update

Ticker: HCWB · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1828673

Sentiment: neutral

Topics: disclosure, corporate-filing

TL;DR

HCW Biologics filed a routine 8-K on 6/5/25. No major news.

AI Summary

HCW Biologics Inc. filed an 8-K on June 5, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 2929 N. Commerce Parkway, Miramar, Florida, 33025, and its telephone number, 954-842-2024. No specific financial transactions or material events beyond routine reporting are detailed in the provided text.

Why It Matters

This filing serves as a standard disclosure for HCW Biologics Inc., providing updated corporate information and indicating the submission of financial statements and exhibits.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure without any immediate indication of significant financial changes, new risks, or material events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by HCW Biologics Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 5, 2025.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on June 05, 2025.

What is the principal executive office address for HCW Biologics Inc.?

The principal executive office address for HCW Biologics Inc. is 2929 N. Commerce Parkway, Miramar, Florida, 33025.

What is the telephone number for HCW Biologics Inc.?

The telephone number for HCW Biologics Inc., including area code, is 954-842-2024.

What is the state of incorporation for HCW Biologics Inc.?

HCW Biologics Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding HCW Biologics Inc. (HCWB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing